Company / Interest Expense
CUMBERLAND PHARMACEUTICALS INC Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$496.0K
FY2025
5-year range
$98.0K / $667.9K
FY2021-FY2025
Trend
-25.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has fluctuated over the past 10 years, ranging from $67,074 in FY2016 to $667,861 in FY2024.
Based on SEC 10-K filings.
$495,990 in FY2025 with a 5-year CAGR of +13.5%.
Improved from $585,995 to $495,990 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +71.7%
- 5-Year CAGR
- +13.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +13.5%, indicating consistent growth.
- In FY2025, interest expense decreased 25.7% year-over-year.
- Peak interest expense was recorded in FY2024.
- Lowest interest expense in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $496.0K | -25.7% |
| FY2024 | $667.9K | +14.0% |
| FY2023 | $586.0K | +497.8% |
| FY2022 | $98.0K | -60.2% |
| FY2021 | $246.2K | -6.6% |
| FY2020 | $263.6K | +7.1% |
| FY2019 | $246.2K | +131.4% |
| FY2018 | $106.4K | +44.1% |
| FY2017 | $73.9K | +10.1% |
| FY2016 | $67.1K | -35.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026